In a decision signed Monday, North Carolina federal judge Kenneth Bell granted Merck’s motion to dismiss the claims of ...

The Company now also plans to submit a label extension application to the UK MHRA. Valneva is focused on expanding the vaccine’s label and access. In the third quarter of 2024, the Company expanded ...

Topline data expected as early as mid-2025 - SOUTH SAN FRANCISCO, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced the initiation of a Phase 1, open label, dose ...

There sat Robert F. Kennedy Jr., the nation’s top health official, at a Steak ’n Shake with Fox News host Sean Hannity, ...

Valneva is focused on expanding the vaccine’s label and access. In the third quarter of 2024, the Company expanded its partnership with CEPI12, with support from the EU Horizon Europe program ...

If granted, IXCHIQ ® will become the first vaccine against the chikungunya virus ... and a decision on the label extension application of IXCHIQ ® in the European Union (EU), Norway ...

Valneva is focused on expanding the vaccine's label and access. In the third quarter of 2024, the Company expanded its partnership with CEPI 12, with support from the EU Horizon Europe program, ...

Stephen Krahling was a published cancer researcher when vaccine maker Merck brought him on board as a virologist in 1999. That’s when he says he found himself embroiled in an all-hands-on-deck ...

but disputes the anti-vaccine label. Although Makary has staked out contrarian positions on other topics in the past, those familiar with his work say he believes in the benefit of vaccination.

House Republicans’ funding patch includes cutting funds for the Congressionally Directed Medical Research Programs, an agency ...